Top 50 Biotech VC (Venture Capital) Funds in Japan in February 2025
A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Japan. We rank investors based on the number of investments they made in Biotech companies from Japan. We update this investor list every month.Top 50 Biotech VC (Venture Capital) Funds in Japan in February 2025
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Investment focus
- Manufacturing, Biotechnology, Robotics
- Funding Round, Seed, Series A
- Japan, Singapore, India
Portfolio highlights
- Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
- Mjolnir Spaceworks — Mjolnir Spaceworks desings and manufactures state-of-the-art novel space rockets with efficient engines as well as other space equipments.
- Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Investment focus
- Information Technology, Software, Manufacturing
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Leading Mark — Leading Mark, a rising human resources startup in Japan. Leading Mark is branching out into mid-career and international hiring. It currently has a one-man team in China working to bring the top Japanese-speaking Chinese students to domestic companies. He also touts his startup’s focus on the average job seeker. “We want to make sure that the usersget the info that he or she needs the most,” he says. Large scale, legacy players can sometimes prioritize the needs of the hiring company, and their commission, over the needs of applicants themselves. This leads to frustration and short-circuited careers.
- Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.
The firm was founded in 2014 and based in Osaka, Japan.
Investment focus
- Biotechnology, Manufacturing, Health Care
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Red Arrow Therapeutics — Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- Japan, United States, Singapore
Portfolio highlights
- Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
- Liminal — Advanced battery inspection and metrology with ultrasound and machine learning
- Eureka Robotics — Eureka Robotics develop robotics technologies and products to automate the mundane, so that humans can focus on the creative.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Investment focus
- Software, Health Care, Information Technology
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Pleap — Pleap is a medical engineering company specializing in the development of AI and IoT-based technology solutions tailored for medical institutions. The company's product offerings include "medimo" which is an AI tool that automatically creates medical record manuscripts from medical audio.
- Infobox — Infobox is a sales data platform that includes every detail from market research to creating a list of companies and contacting decision-makers.
- Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Investment focus
- Information Technology, Health Care, Software
- Funding Round, Series B, Series A
- Japan, United States, Singapore
Portfolio highlights
- Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
- Hireroo — HireRoo is an online coding test service that checks the skills of engineers through programming tests. It provides problems that correspond to a wide range of levels, from new graduates to mid-career tech leads, engineering managers, and various occupations. They also provide coding test planning and execution services.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- BlueWX — BlueWX is a software company that develops predictive content services that supports in forecasting, and weather analysis.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
- Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Series A, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Medii — Medii provides a physician sharing service for hospitals.
- A10 Lab — A10 Lab is a company that aims to makes people happy with technology that is independent of Sony's new business creation program. It provides Google Play an app that allows users to do things that they have never been able to do with the custom app 'Min Chale' selected for two consecutive years. It is a company that brings profits tocompanies by improving lifetime value (sales) through the habitation of users that companies have.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization).
The firm was founded in 2014 and based in Tokyo, Japan.
Investment focus
- Manufacturing, Biotechnology, Medical
- Funding Round, Series A, Seed
- Japan, Singapore, Austria
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more
Investment focus
- Information Technology, Software, Internet
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Torihada — Torihada is a creative firm specializing in influencer marketing, creating content, and digital marketing.
- MOSH Japan — MOSH is a web page creation services for individual business owners.
- Gaudi Clinical — Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series A, Funding Round
- Japan, South Korea, United States
Portfolio highlights
- Newmo — newmo delivers sustainable local public transportation create a user experience (UX) that people may utilize with peace of mind and comfort.
- Lazuli — Lazuli is a SaaS platform that enables companies to utilize data for analysis, search, recommendation, marketing & supply chain management.
- AI model — AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more
Investment focus
- Software, Health Care, Internet
- Funding Round, Series A, Seed
- Japan, United States, Australia
Portfolio highlights
- Precal — Precal is an information technology company that develops applications that are common with pharmacies, pharmacists, and dispensing clerks.
- Linqmed — Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
- MOSH Japan — MOSH is a web page creation services for individual business owners.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Investment focus
- Health Care, Internet, Medical
- Funding Round, Seed, Series A
- Japan, United States, Ethiopia
Portfolio highlights
- HQ — HQ offers next-generation employee benefits platform.
- Doctor's Prime — Doctor's Prime is a technology company that provides is a part-time job information service for optimizing the working style of doctors.
- Qlay — Qlay is an AI-automated global engineer hiring platform
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- OptQC — OptQC commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory. Because optical quantum computers are more scalable than superconducting and other quantum computing implementations, OptQC's optical quantum computers should reach this scale. They also have benefits like faster processing andreduced power consumption, which makes optical quantum computers a possible long-term pinnacle of quantum technology.
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Investment focus
- Health Care, Manufacturing, Information Technology
- Funding Round, Seed, Series A
- Japan, United States, Myanmar
Portfolio highlights
- CoCooking — CoCooking uses food and cooking to create ample opportunity for dialogue and thought, fostering creativity, diversity, and well-being of individuals and communities.
- TelaAxon — TelaAxon develops artificial intelligence technology for sustainable operations, enhancing human-AI coexistence, safety, and wellness.
- Second Heart — Second Heart is a medical center that offers preventive diabetic care and awareness programs to avoid foot amputations.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Gecipe — Gecipe is a video service for e-sports players.
- Awarefy — Awarefy is a mental health tech startup that offers CBT-based apps to maximize well-being.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- ACCEL Stars — ACCEL Stars is a fitness and wellness firm that offers sleep diagnosis and examinations like sleep health, hygiene and medical devices.
- KOALA Tech — Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Series B, Seed
- United States, Japan, Canada
Portfolio highlights
- Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
- Cyrano Therapeutics — Cyrano Therapeutics is the leader in Smell Loss therapy and smell loss research. Recover your sense of smell today!
- KisoJi Biotechnology — KisoJi is a leading next-generation antibody company developing multi-specific antibodies to address difficult targets in oncology and other diseases
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, United Kingdom, China
Portfolio highlights
- Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
- Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
- Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Investment focus
- Software, Information Technology, E-Commerce
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Kaguoku — Kaguoku develops and provides the AI-based home staging services. It offers a service that uses AI to process interior photos of real estate properties to increase the property's ability to attract customers.
- Time Prediction — Time Prediction focuses on development of diagnostic pharmaceuticals, drugs and medical devices for the treatment of neurological diseases.
- Mjolnir Spaceworks — Mjolnir Spaceworks desings and manufactures state-of-the-art novel space rockets with efficient engines as well as other space equipments.
Senshu Ikeda Capital offers financial consultancy services.
Investment focus
- Software, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- iYell — iYell Mortgage Platform consists of three pillars, Media that can be used for marketing, Technology to make the procedure more efficient.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Investment focus
- Medical, Biotechnology, Manufacturing
- Series A, Funding Round, Seed
- Japan
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Investment focus
- Software, FinTech, Internet
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Glorang — Glorang is an educational application for university support system.
- Habitto — Habitto by SJ Mobile Labs is a new financial services venture focused on the Japanese market. The team and its advisors have a breadth of experience ranging from insurance, banking, e-commerce, adtech and ventures across five continents. This provides them with a unique approach to entering new markets and building valuable businesses.
- Rebellions — Rebellions builds energy-efficient AI accelerators optimized for Generative AI workloads
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series C, Funding Round
- Japan, Singapore, Thailand
Portfolio highlights
- Linqmed — Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
- MOSH Japan — MOSH is a web page creation services for individual business owners.
- Gaudi Clinical — Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments.
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Funding Round, Corporate Round
- United States, Japan, China
Portfolio highlights
- Ascentage Pharma — As one of the leading clinical stage biopharmaceutical companies, we develop innovative therapies for global medical needs. Our biotech company is engaged in developing novel approaches for treating cancer.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Atlanta Community Food Bank — We're on a mission to end hunger in our community. Learn more about how the Atlanta Community Food Bank provides hunger relief to families in need.
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Investment focus
- Electronics, Medical Device, Artificial Intelligence
- Seed
Portfolio highlights
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Cyto-Facto — Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Swan — Use Swan's APIs to embed white-labeled banking features like accounts, cards, and IBANs into your workflows and UX.
- Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Funding Round, Series B, Series A
- Japan, United States, China
Portfolio highlights
- Blue Skies Space — Blue Skies Space provides access to space science data from low-cost space missions.
- Blue Laser Fusion — Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor.
- Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more
Investment focus
- Biotechnology, Medical, Manufacturing
- Series A, Funding Round, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Issin — Issin manufactures bath mats that can measure weight and automatically record daily weight changes on your smartphone.
- BlueWX — BlueWX is a software company that develops predictive content services that supports in forecasting, and weather analysis.
- Leading Mark — Leading Mark, a rising human resources startup in Japan. Leading Mark is branching out into mid-career and international hiring. It currently has a one-man team in China working to bring the top Japanese-speaking Chinese students to domestic companies. He also touts his startup’s focus on the average job seeker. “We want to make sure that the usersget the info that he or she needs the most,” he says. Large scale, legacy players can sometimes prioritize the needs of the hiring company, and their commission, over the needs of applicants themselves. This leads to frustration and short-circuited careers.
Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.
Investment focus
- Medical, Biotechnology, Nursing and Residential Care
- Series A, Funding Round, Series B
- Japan, Kenya, Nigeria
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
- Revital Healthcare — Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and bloodcollection tubesThe company was established in 2006 and is headquartered in Kilifi, Kenya.
Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals
Investment focus
- Medical, Biotechnology, Genetics
- Series A, Funding Round
- Japan
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more
Investment focus
- Biotechnology, Medical Device, Medical
- Series A, Funding Round, Series B
- Japan, Israel, United States
Portfolio highlights
- Ripcord — Ripcord is a robotics company that combines hardware and software robotics via an integrated SaaS offering. Its focus is on smart robotics digitization, smart content management with AI, and helping enable RPA and business processes.Ripcord is based in Hayward, California, and is backed by leading investors Kleiner Perkins Caufield & Byers,Google Ventures, Lux Ventures, Legend Star, and Apple Co-Founder Steve Wozniak.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- 24M Technologies — 24M Technologies develops energy storage systems for grid and transportation applications. 24M Technologies, Inc. builds energy storage systems for grid and transportation applications. The company was founded in 2010 and is based in Cambridge, Massachusetts.
Chugin Capital Partner is a venture capital firm.
Investment focus
- Communities, Health Care, Biotechnology
- Seed, Series A, Series B
- Japan
Portfolio highlights
- ByWill — ByWill creates and distributes environmental value while eventually becoming carbon neutral.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
- Better Place — Better place vision is to create a world in which kind people can continue to be kind, as well as a society in which people can work in their own way without worrying about money.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Investment focus
- Consulting, Information Technology, Software
- Seed, Series A, Funding Round
- Japan
Portfolio highlights
- Amptalk — Amptalk is a software development firm specializing in operating automatic transcription and analysis of online business negotiations.
- PartnerProp — PartnerProp is a PRM tool with outstanding potential and a wide variety of capabilities that resolves all partner business difficulties.
- Simple Form — Simple Form provides real-time information on all domestic corporations necessary for financial institutions. We will accelerate the time-consuming and labor-intensive research work of corporations and take on the role of new financial underpinnings.
Kobe University Capital is create new indstry academia cllabration and technology transfer models.
Investment focus
- Apps, Health Care, Health Diagnostics
- Series A
- Japan
Portfolio highlights
- Pittan — PITTAN is a health tech startup that focuses on the development of high-speed analytical equipment for use in the healthcare industry. The company's primary service is to analyze the internal status of an individual's body to promote beautiful and healthy skin. This is achieved through the application of analytical chemistry.PITTAN's services are designed to provide insights into the body's health, which can be used to inform personal care and wellness decisions.
- TelaAxon — TelaAxon develops artificial intelligence technology for sustainable operations, enhancing human-AI coexistence, safety, and wellness.
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Investment focus
- Manufacturing, Task Management, Medical
- Funding Round, Series A, Series B
- Japan
Portfolio highlights
- Thinca — Thinca is an IT system planning, development, and operations company that provides a cloud-based CTI (Computer Telephony Integration) hospitality & communication solution for corporate offices.
- Towing — Towing is an agricultural company that provides farming, manufacturing, and recycling services.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Tokyo Century is a diversified leasing business (leasing, installment sales, and other financial services for IT-related equipment, industrial equipment, and other machinery and facilities). Tokyo Century has various types of financing and is an international business.
Investment focus
- Transportation, Internet of Things, Robotics
- Funding Round, Series A, Private Equity
- Japan, Singapore, United States
Portfolio highlights
- KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
- Spiber — Established in September 2007, Spiber Inc. is a Japanese biotechnology startup utilizing cutting-edge synthetic biology, polymer, and material science for the development of its novel Brewed Protein™ materials. Produced through microbial fermentation and utilizing agricultural feedstocks as primary raw materials, Brewed Protein™ polymers arewell-positioned to make significant contributions to animal- and plastic-free initiatives in a range of fields such as the apparel and automotive industries. Leveraging its R&D expertise, Spiber pursues its mission of positively contributing to sustainable human well-being. Operation of Spiber’s first mass production plant in Rayong Province, Thailand, is slated to commence within 2021. The company is also constructing a second mass production facility with partner ADM in Iowa, USA, which is scheduled to begin operating in 2023 at the earliest.
- Terra Motors — Terra Motors is an electric car manufacturing company that utilizes IoT and digitally connecting EV mobility. They develop the global enterprise for global warming. SEED48 is the first electronic motorcycles that have brilliant functionality such as the highest speed(40km/h)and practicality(40km/1charge) Their products are provided at thefamous electronic retail stores, do-it-yourself stores, bicycle stores, car stores, and gas stations. They achieve a dominant share of the electronic motorcycles market.In 2011, They would mainly focus on the south east Asian market.
Innovation Network Corporation of Japan (INCJ) is a public-private partnership aimed at promoting innovation and enhancing value.Leveraging the rich history of Japanese technological prowess, INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through “openinnovation,” or the flow of technology and expertise beyond the boundaries of existing organizational structures.INCJ will draw on funding as well as management and technological expertise from the public and private sectors. INCJ is actively reviewing various investment opportunities in areas of green energy, electronics, IT and biotechnology to infrastructure-related sectors such as water supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of INCJ's Innovation Network Committee, which will make the final investment decisions.INCJ is capitalized at 280 billion yen, with the Japanese government injecting 266 billion yen and 26 private corporations (refer to details in Appendix below) providing a further 14 billion yen. The government will also provide guarantees up to a total of 1,800 billion yen for INCJ investments, giving it an investment capability of approximately 2,000 billion yen. INCJ will be established for a period of 15 years.
Show more
Investment focus
- Manufacturing, Software, Robotics
- Funding Round, Series B, Series A
- Japan, United States, United Kingdom
Portfolio highlights
- Cloudian — Cloudian provides exabyte-scale storage for your capacity-intensive workloads: S3-compatible storage for on-prem, hybrid cloud, and multi-cloud.
- Seajacks — Cadeler is a global leader in offshore wind farm construction, maintenance, and decommissioning.
- Vehicle Energy Japan — Vehicle Energy Japan specializes in development, manufacturing and sales of automotive lithium-ion batteries.
THVP is a venture capital corporation for startup innovation. It was established in 2015 and is based in Nagoya, Japan.
Investment focus
- Medical, Nursing and Residential Care, Manufacturing
- Series A, Seed, Series C
- Japan
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Hakko Holdings — Hakko Holdings is a food-tech company that specializes in producing and manufacturing fermented plant-based food with unique fermentation technology for healthy and sustainable lives.
Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. They are proud that their ability to supply a vast array of products and information allows us to serve theneeds of all of their customers. By making full use of their international network, coupled with the highest quality information, they support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed
- Japan
Portfolio highlights
- Fimecs — FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
- Lab Biotech — Lab Biotech manufactures, conducts research, devises plans, and consults with pharmaceutical and food manufacturers.
Fuyo General Lease focuses in the leasing and installment sales trading of equipment and fixtures, and financial transaction. The company provides leasing services of information-related equipment, office equipment, and industrial equipment, installment sales of commercial facilities, production facilities, and hospital facilities. It also providessecurities management services and anonymous association composition.Fuyo General Lease was founded on 1969 and is headquartered in Tokyo, Japan.
Show more
Investment focus
- Manufacturing, Biotechnology, Sales
- Series A, Funding Round, Corporate Round
- Japan
Portfolio highlights
- avatarin — avatarin develops next-generation mobility and human augmentation platforms.
- A.L.I.Technologies — Aerial Lab Industries focuses on research and development of UAV (unmanned miniature aircraft).
- 3D Printing Corporation — 3D Printing Corporation provides 3D printing technology solutions.
The Awa Bank provides financial services such as deposits, loans, and foreign exchange transaction.
Investment focus
- Software, Automotive, Taxi Service
- Series A, Funding Round
- Japan
Portfolio highlights
- DennoKotsu — Denno Kotsu is a Taxi dispatch system development and provision, taxi company contract dispatch service
- Setsuro Tech — Seturotech Co., Ltd. is a biotechnology venture company established on February 22, 2017 by Tatsuya Takemoto (PI: Principal Investigator) of the University of Tokushima as a venture from Tokushima University. In 2015, Takemoto and Masakazu Hashimoto (Osaka University) developed a simple and highly efficient method for producing genetically modified(genome-edited) mice using CRISPR / Cas9, and filed a patent application for the technology. The technology is called fertilized egg electroporation (GEEP method), a technology that introduces molecules required for genome editing by CRISPR into fertilized eggs at high throughput by the power of electricity (electroporation). Using this technology, Seturotech will start from the production and sale of genetically modified mice, and will become a fundamental company providing all genetically modified animals, anticipating the future use of genetically modified animals in industry.
TechAccel Ventures is a Seed and Early-Stage Venture Capital firm focused on technology startups in Japan. The firm contributes to the development of the Japanese industry by providing investment and support based on a technical perspective.
Investment focus
- Manufacturing, Information Technology, Information Services
- Funding Round, Series A, Series B
- Japan, United States
Portfolio highlights
- SIRU+ — SIRU+ is a startup that enables you to convert consumer purchasing data into nutrients and visualize and quantify consumer shopping trends. Through the app developed by the company, consumers can know their nutrition status. The service “SIRU+ (SIRU+)” is an app that lets you know the nutrition of what you bought by simply registering a super pointcard.
- EAGLYS — EAGLYS provides a platform for secure computing and AI.
- KOALA Tech — Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.
Investment focus
- Financial Services, FinTech, Information Technology
- Series B, Series A, Funding Round
- Japan, United States, United Kingdom
Portfolio highlights
- Sakana AI — We are creating a new kind of foundation model based on nature-inspired intelligence.
- UBX Philippines — UBX Philippines is a fintech company passionate about creating opportunities and access for all by building solutions.
- Preferred Networks — Preferred Networks (PFN) was established in March 2014 in Tokyo with the goal to develop practical, real-world applications of deep learning, robotics and other latest technologies. PFN is currently focused on three priority areas – transportation systems, manufacturing and bio-healthcare – and also exploring the use of deep learning in personalrobots, plant optimization, materials discovery, sports analytics and entertainment. PFN has a U.S. subsidiary in Burlingame, California.
Higegin Capital is a venture capital firm.
Investment focus
- Biotechnology, Software, Medical
- Funding Round, Series A, Seed
- Japan
Portfolio highlights
- F.MED — F.MED is a manufacturing company that designs and develops robotic microsurgical devices for the healthcare industry.
- REVORN — REVORN is a fragrance AI and DX research and development company. They develop products such as odor sensors that can respond to odor issues and needs. They provide consultation at a range of levels, from identifying issues to developing solutions.
- Manpuku Holdings — Manpuku Holdings is a food and beverage company that specializes in sushi, yakiniku, fried chicken, bento, and rice balls.
The Japan Medical Device Development Organization aims to activate Japan's medical innovation and medical device industry, centering on the medical device incubation business, and aim for Japan to become a world leader in this field.Japanese Organization for Medical Device Development is a country of craftsmanship, possesses high technicaland quality control skills, and should be good at producing medical equipment. However, in the medical device field, imports exceed 600 billion yen every year. Japan's “manufacturing” technology has not been fully utilized.
Show more
Investment focus
- Biotechnology, Laser, Medical
- Seed, Series A, Funding Round
- Japan, United States
Portfolio highlights
- Luxonus — Luxonus is a product development of a new imaging device using optical ultrasonic technology.
- Meltin MMI — Meltin MMI is a cyborg-technology company that focuses on biosensors and robotic arms. Meltin has successfully enabled fine finger movements, such as for amputees and participated in Cybathlon 2016 and won the Microsoft Innovation Award.
- Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
Glocalink provides seed funding and comprehensive support for emerging science & technology entrepreneurs. Members of Glocalink have extensive experiences of bringing laboratory technologies to the market. On top of seed funding, we will provide comprehensive supports for overcoming all the hurdles that science / technology entrepreneursface.
Investment focus
- Health Care, Robotics, Task Management
- Funding Round, Seed, Series A
- Japan, Singapore
Portfolio highlights
- MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
- ExtraBold — ExtraBold specializes in the development of 3D printers.
- ProfilePrint — Helping agribusinesses buy and sell better, ProfilePrint is powered by a patented digital food identity-as-a-service (IDaaS) technology. ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Investment focus
- Medical, Software, Health Care
- Seed, Series A, Funding Round
- Japan
Investors by industry
Biotech
Energy
Health Care
Hardware
Gaming
Google
Artificial intelligence
Climate
Proptech
Community
FinTech
Consumer
Marketplace
Impact
EdTech
Sustainability
Venture Capital
Retail
Clean Energy
Finance
Education
Organic Food
Big Data
Web3
Food and Beverage
Financial Services
Payments
B2B
Real Estate
Publishing
Video Games
Beauty
Infrastructure
Photography
Medical
Social Network
Wellness
Music
Franchise
Mobile
Internet
Legal
Android
eSports
Construction
Sports
Enterprise Software
Social Media
Email
Art
Digital Media
Manufacturing
Local
Cannabis
Biotechnology
Recruiting
Fitness
Hospitality
Platforms
Mobile Advertising
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Oil and Gas
Fashion
Theatre
Life Science
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
United Kingdom
Germany
United States
South Korea
Canada
Ireland
Australia
New Zealand
Oceania
LATAM
Africa
Asia
Japan
Saudi Arabia
China
Singapore
Spain
Vietnam
Armenia
South Africa
Middle East
Sri Lanka
Brazil
Indonesia
Europe
Faroe Islands
Barbados
Denmark
Qatar
Chile
Liechtenstein
Ecuador
Ethiopia
Estonia
Hong Kong
France
Gibraltar
Morocco
Costa Rica
Greece
Finland
Croatia
Egypt
Georgia
Algeria
Ghana
Liberia
Bulgaria
Bermuda
Hungary
Lebanon
Czech Republic
Bahrain
Belize
Belgium
Lithuania
Belarus
Serbia
Ukraine
Uganda
Uzbekistan
Thailand
Portugal
Kuwait
Senegal
Sierra Leone
Venezuela
Philippines
Russian Federation
Tajikistan
Rwanda
Zimbabwe
Zambia
Seychelles
Taiwan
Sweden
El Salvador
Tunisia
San Marino
Poland
Turkey
Puerto Rico
Uruguay
Mexico
Slovenia
Togo
Tanzania
Dominican Republic
Norway
Iraq
Nigeria
Jersey
Bahamas
Namibia
Mauritius
Azerbaijan
Iceland
United Arab Emirates
Israel
Jamaica
Honduras
Malaysia
Isle of Man
Bolivia
Luxembourg
Peru
Pakistan
Albania
Malta
Myanmar
Italy
Mali
Bangladesh
Nicaragua
Grenada
Romania
Jordan
Argentina
Panama
Kenya
Kazakhstan
Cayman Islands
Cambodia
Latvia
Oman
Cyprus
Colombia
Cameroon
Austria
Switzerland
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Japan by industry
Crowdfunding
Restaurants
Real Estate
Financial Services
Transportation
Big Data
Cryptocurrency
Finance
Climate
Food and Beverage
Wine And Spirits
Video Games
Medical
Medical Device
Wellness
Internet
Social Media
Digital Media
Manufacturing
Art
Music
Mobile
Android
Blockchain
Software
Legal
Local
Construction
Enterprise Software
Sports
Fitness
Hospitality
Automotive
Travel
InsurTech
FinTech
Recruiting
Biotechnology
Enterprise
Consumer
Health Care
Biotech
Energy
EdTech
Sustainability
Proptech
SaaS
Marketplace
Hardware
Gaming
Retail
Fashion
Beauty
B2B
Life Science
Sporting Goods
Publishing
Photography
Education
Renewable Energy
Social
Mobile Apps
Social Network
Platforms
Clean Energy
Payments
Artificial intelligence
Infrastructure
Web3
Social Impact
Media (entertainment)
CleanTech
Impact
Community
eSports
Agriculture (agtech)